P Liebisch, S Eppinger, C Schopflin, G Stehle, G Munzert, H Dohner and M Schmid (2005) “CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13q”, Haematologica. Pavia, Italy, 90(4), pp. 489-493. Available at: https://haematologica.org/article/view/3479 (Accessed: 27September2026).